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Controlling pyridinium-zwitterionic ligand ratio on atomically 
precise gold nanoclusters allowing for eradicating Gram-positive 
drug-resistant bacteria and retaining biocompatibility
Zeyang Panga,b, Qizhen Lia, Yuexiao Jiaa, Weixiao Yana, Jie Qia, Yuan Guoc, Fupin Hud, Dejian 
Zhou*,b, and Xingyu Jiang*,a
Abstract: Infections caused by multidrug-resistant (MDR) bacteria are an increasing global healthcare concern. In this study, 
we developed a dual-ligand-functionalised Au25(SR1)x(SR2)18−x-type gold nanocluster and determined its antibacterial activity 
against MDR bacteria strains. The pyridinium ligand (SR1) provided bactericidal potency and the zwitterionic ligand (SR2) 
enhanced the stability and biocompatibility. By optimising the ligand ratio, our gold nanocluster could effectively kill MDR 
Gram-positive bacteria via multiple antibacterial actions, including inducing bacterial aggregation, disrupting bacterial 
membrane integrity and potential, and generating reactive oxygen species. Moreover, combining the optimised gold 
nanocluster with common antibiotics could significantly enhance the antibacterial activity against MDR bacteria both in vitro 
and animal models of skin infections. Furthermore, the fluorescence of the gold nanocluster at the second near-infrared 
(NIR-II) biological window allowed for the monitoring of its biodistribution and body clearance, which confirmed that the 
gold nanoclusters had good renal clearance and biocompatibility. This study provides a new strategy to combat the MDR 
challenge using multifunctional gold nanomaterials.
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Introduction
Since the discovery of antibiotics in 1928, the unrestrained 
global use of antibiotics has imposed a highly selective 
pressure on all bacterial species, which has accelerated the 
acquisition and accumulation of drug-resistant genes via 
horizontal transmission.1 Several multidrug-resistant (MDR) 
pathogens, or the so-called ‘superbugs,’ have emerged over 
the past 50 years.2,3 Moreover, some drug-resistant bacteria 
that were previously considered less harmful, like Methicillin-
resistant Staphylococcus epidermidis (MRSE), have gained 
much attention due to its role in the development of drug-
resistant strains.4,5 The widespread of MRSE inevitably 
increases the risk of infection and promotes intra- and inter-
species horizontal transfer of the MDR gene.6 MDR-related 
infections has imposed a significant burden on the world 
economy and healthcare systems, yet, the development of 
new antibiotics has largely stalled over the past 20 years. 7 
Therefore, there is an urgent need to develop new strategies 
to address this significant global health problem.
Recently, gold nanomaterials, including gold nanoparticles 
(GNPs),8,9,10 gold nanorods (GNRs)11 and gold nanoclusters 
(GNCs),12,13 have emerged as potentially effective antibacterial 
agents. They can exhibit several antibacterial actions, such as 
delivering antibiotics, producing reactive oxygen species (ROS) 
and offering photothermal treatments.14,15 Among which, the 
sub-2 nm GNCs have a distinct advantage of readily renal 
clearance, which can greatly reduce the potential long term 
toxicity.16 Recent studies have focused on synthesising 
atomically precise GNCs17 to achieve better quality control, 
which is important for potential clinical approval. Among all 
formula-precise GNCs, the Au25(SR)18 type GNC is the most 
widely studied owing to its high stability, low toxicity, feasible 
preparation and stable near-infrared (NIR) fluorescence,18 
making it a powerful tool for bioimaging, drug delivery and 
therapy.19,20 However, most Au25(SR)18 GNCs reported so far 
are capped with a single-type ligand, limiting the ability to 
tune their biocompatibility and antibacterial potency, as the 
requirements for the two are often incompatible. 
Consequently, most antibacterial nanomaterials have only 
demonstrated effectiveness in vitro but not in vivo.12 
Herein, we synthesised a pyridinium-zwitterionic dual-ligand 
functionalised Au25(SR1)x(SR2)18−x GNC to address MDR 
bacteria-induced infections, especially MRSE (Figure 1A). The 
pyridinium ligand is derived from cetylpyridinium chloride 
(CPC), a commercial mouth mucosa aseptic addictive 
approved by the US Food and Drug Administration, which 
affords antibacterial ability although it suffers poor prospect 
of in vivo applications.21,22 The zwitterionic (ZW) ligand was 
introduced due to its biocompatibility, biosafety, and low 
biofouling properties.23,24 Previously, our group and other 
researchers showed that ZW ligand-coated nanoparticles are 
highly stable, biocompatible and strongly resist biofouling.25,26 
By adjusting the GNC surface capping pyridinium/ZW ligand 
ratio, GNCs that displayed low cytotoxicity and excellent 
antibacterial activity against clinically isolated Gram-positive 
drug-resistant species were obtained. Besides, we discovered 
that the combination of our GNCs with conventional 
antibiotics could significantly enhance the bactericidal 
potency against MRSE, allowing us to overcome MDR bacterial 
infections at the cellular level and in vivo skin infection models. 
Furthermore, we exploited the stable NIR-II fluorescence of 
our GNC to directly monitor the in vivo biodistribution, 
revealing that the GNC was efficiently cleared without 
inducing observable long-term toxic effects. All these results 
show that our optimised Au25(SR1)x(SR2)18-x GNC is a new 
generation of multifunctional fluorescent nanomaterial for 
treating MDR bacterial infections induced by Gram-positive 
strains.























































































































Journal Name  ARTICLE
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 3
Please do not adjust margins
Please do not adjust margins
Figure 1. (A) A schematic diagram of this study. GNCs with a specific P12/C5 composition aggregate planktonic bacteria by interacting with the bacterial cell envelope while 
maintaining good biocompatibility. Local interactions of GNCs with bacteria cause cell content leakage and structural deformation, which induce cell death. The distribution of 
GNCs is tracked using NIR fluorescence upon excitation with 808 nm laser. Golden spheres indicate gold atoms, red spheres indicate the P12 ligands, blue spheres indicate the 
C5 ligands.  (B) Time-dependent evolution of the UV–vis spectra of 100% C5-capped GNC (representative species) during the synthesis process. (C) NIR fluorescence excitation 
(black line, monitored with λEM = 1100 nm) and emission (red line, λEX = 810 nm) spectra of 100% C5-capped GNC. (D) Double spherical aberration-corrected TEM images (scale 
bar: 10 nm) of 100% C5-capped GNC prepared on an ultra-thin carbon film copper mesh. The UV-vis spectra, NIR fluorescence spectra and TEM images of GNCs with other 
P12/C5 composition has no obvious differences with this representative species. (E) A plot of the GNC surface P12 capping ratio versus the P12-feeding ratio. The red line 
indicates the theoretic output, assuming no ligand affinity difference, whereas the black dots represent the actual P12 ratio. (F) HD5/MIC values for dual-ligand GNCs prepared 
under different P12 feeding ratio. The greater the HD5/MIC, the higher the biosafety and antibacterial ability of the material. A sudden change in haemolytic potency appears as 
the feeding ratio approaches 50% (MIC value is from anti-S.aureus result). (G) Comparison of the cytotoxicity of the 45%- and 50%-P12 GNCs toward human umbilical vein 
endothelial cells (HUVECs) with 24-h incubation.
Results and Discussion
Synthesis and characterisation of Au25(SR1)x(SR2)18-x-type 
GNCs 
In this study, alkyl-thiolated ZW and pyridinium ligands 
(abbreviated as C5 and P12, hereafter) were synthesised, and 
their chemical structures were confirmed by NMR and mass 
spectrometry (MS), respectively (see Supporting Information 
(SI), Figure S1-9). GNCs with different surface ligand capping 
were then prepared by varying the feeding ratios between 
100% C5 and 100% P12 ligands. The formation of Au25 NC was 
characterised by a UV-visible spectrum (UV-vis) absorption 
peak at ~690 nm with a shoulder at ~810 nm.27 The 
characteristic absorption peak was blue-shifted from ~730 to 
~690 nm during the first 2 h. Then, the spectrum for Au25 NC 
stabilised after 3 h, suggesting that the synthesis of Au25 NC 
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was complete (Figure 1B).28 Using this reaction time, we 
synthesised GNCs with the increasing feeding ratio of P12 
(from 0% to 100%). All mixed P12/C5 groups successfully 
produced the Au25(P12)x(C5)18-x-type GNCs, indicated by 
obvious absorption peaks at 690 nm (see SI, Figure S10).
Under 808 nm laser excitation, the GNCs showed a strong 
fluorescence peak at ~1100 nm with a shoulder at ~950 nm, 
regardless of the ligand composition, which is consistent with 
the previous report29 (Figure 1C). Such fluorescent 
characteristics are ideal for sensitive fluorescence imaging in 
the second near-infrared (NIR-II) biological window, which 
benefits enhanced tissue penetration depth and resolution.30 
Despite having a moderate absolute fluorescence quantum 
yield (0.54%) compared with small molecular NIR-II emitting 
dyes,31,32 our GNCs exhibited higher stability, biocompatibility 
and anti-photobleaching properties, which are extremely 
beneficial to bioimaging.33 
The GNC size prepared under different ligand feeding ratios were 
measured by double spherical aberration-corrected TEM (DSAC-
TEM) analysis, which revealed the GNC granule size to be around 
1.2 nm with negligible difference between each different-ligand 
group (Figure 1D and Table 1). These results are consistent with the 
ultra-small size of Au25 NCs reported in the literature.34
In addition, the zeta potential of GNCs prepared under different 
P12 ligand feeding ratios were measured and summarized in Table 
1. The zeta potential of GNCs was gradually and progressively 
shifted from around -5 mV to > +70 mV as the P12 ligand feeding 
ratio was increased from 0 to 100%, indicating successful 
incorporation of P12 ligand onto the GNC surface. 
The GNCs were further characterised by electrospray 
ionisation MS (ESI-MS), which yielded the general molecular 
formula of diverse Au25(P12)x(C5)18-x (x = 0–18, depending on 
the P12/C5 feeding ratio, see SI, Figure S11). After mass 
deconvolution, the exact mass of the dominant peaks was 
matched with the theoretical molecular weight (Table 1 and, 
SI, Table S1). The relative abundance of each GNC was derived 
from its corresponding peak in the mass spectrum35 and the 
relationship between the GNCs surface ligand composition 
and corresponding ligand feeding ratio was summarized in 
Table 1. It is apparent that except for those prepared with 
100% P12 or 100% C5, all other GNCs prepared were a mixture 
of differently formulated Au25(P12)x(C5)18-x GNCs, which could 
be explained by the putative forming mechanism of GNCs. 
Upon adding the dual-ligand solution to chloroauric acid, the 
thiol groups quickly reduced the trivalent Au(III) ions to Au(I) 
to form the Au(I)-ligand complexes36. Due to the random 
reduction and combination of Au(I) with different capping 
ligands, the complex units would have multiple types. The 
subsequent addition of sodium borohydride to reduce Au(I) 
for cluster formation and sodium hydroxide (for controlling 
ligand etching ability) allowed the precisely reduction of some 
Au(I)-ligand complex to Au(0), forming a stochastic mixture of 
dual-ligand capped GNCs with a variety of ligand capping 
ratios37. However, controlled mainly by our ligand feeding 
ratio, this synthesis condition could allow for some specific 
GNCs to be the main product. The relative abundance of each 
GNC formulation could be derived from the corresponding MS 
peak intensity.35


































































































A plot of the average content of P12 in the GNCs against the 
feeding ratio (Figure 1E) revealed that the product line was 
mostly below the feeding line. Therefore, the C5 ligand 
appeared to bind more strongly to the gold kernel than P12, 
possibly because of the lower electrostatic repulsion among 
the C5 (neutral overall) over P12 (positively charged) ligands. 
The only exception was observed at a feeding ratio of 40%–
45%, where the product composition (mainly 
Au25(P12)8(C5)10) matched the feeding ratio, suggesting that 
the products of this ligand ratio were exceptionally stable.
Antibacterial screening
The antibacterial activity of GNCs was assessed using a few 
common Gram-positive (Staphylococcus aureus and MRSA) 
and Gram-negative (Escherichia coli, Klebsiella pneumonia and 
Pseudomonas aeruginosa) species (Table 2 [16 h] and SI, Table 
S2 [24 h]). The relationship between the antibacterial activity 
and the P12 ligand feeding ratio (i.e. surface positive charge 
density) of GNCs was interesting: first, the activity increased 
with the increasing P12 ligand feeding ratio (up to 50%), then 
there was a slight decrease (from 50% to 70%), and finally it 
increased again (from 70% to 100%). This trend was totally 
unexpected; since the antibacterial properties of GNC was 
mainly derived from the incorporated, positively charged P12 
ligands, and not the C5 ligands; we had anticipated the 























































































































Journal Name  ARTICLE
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 5
Please do not adjust margins
Please do not adjust margins
antibacterial activity to be positively correlated with the P12 
content (GNC surface positive charge density). The fact that 
the GNC with a 50% P12-feeding ratio exhibited comparable 
antibacterial activity to that with 100% P12 ligand suggests 
that there must be an optimal window to tune the GNC 
antibacterial properties and biocompatibility.
Table 2. Antibacterial activity of different GNCs against five common pathogens 
(the colour code represents the antibacterial activity: red for high, yellow for 
medium, green for low and grey for negligible, and the same below).














0 >128 >128 >128 >128 >128
10 >128 >128 64 64 128
20 128 128 64 64 64
30 >128 >128 32 64 64
40 128 128 64 32 32
45 32 64 32 8 16
50 32 32 16 8 8
60 64 64 16 32 32
70 64 64 32 16 16
80 64 64 32 16 32
90 32 32 8 16 32
100 32 32 32 8 8
*MIC—Minimum inhibitory concentration
**Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa are 
Gram-negative bacteria.
***Staphylococcus aureus and Methicillin-resistant Staphylococcus aureus 
(MRSA) are Gram-positive bacteria.
Table 2 reveals that the GNCs were more potent towards 
Gram-positive strains than towards Gram-negative ones. This 
phenomenon can be attributed to the differences in the 
surface structure between Gram-positive and -negative 
bacteria. The surface of Gram-positive bacteria is negatively 
charged;38 thus, they exhibit a strong electrostatic interaction 
with cationic materials. For example, wall teichoic acid (WTA), 
a distinct cell wall component in Gram-positive bacteria, 
consists of repeating poly(glycerol phosphate) units and a 
phosphodiester terminus. WTA constitutes the polyanionic 
network, making the cell envelope highly negatively charged 
and susceptible to the binding of cationic materials.39,40 
Besides, anionic lipids, such as phosphatidylglycerol (PG) and 
cardiolipin, constitute ~80% of the total lipids in Gram-positive 
bacterial membranes but only ~30% in Gram-negative 
strains.41,42 Moreover, negatively charged phospholipids, such 
PGs, are present on both sides of bacterial cell membranes 
rather than only the inside membrane found on mammalian 
cells. This difference can provide selectivity between 
mammalian cells and bacteria for some positively changed 
antibacterial agents.43
Table 3. The antibacterial activity toward Gram-positive bacteria of selected GNCs.





























45 8 16 8 8 32 32 32 16
50 8 8 8 8 32 32 32 16
100 8 8 4 4 8 8 16 16
As shown in Table 2, the three best-performing GNCs (45%, 
50% and 100% P12 feeding ratio) were selected for further 
tests using more Gram-positive strains, including 
Staphylococcus epidermidis, Staphylococcus haemolyticus, 
Enterococcus faecium and their corresponding drug-resistant 
strains (MRSE, MDR S. haemolyticus and VRE). Table 3 reveals 
that although the GNCs with 100% P12 exhibited the best 
antibacterial potency among the three groups, especially 
against MRSE, those with 45% and 50% P12 feeding also 
showed similar activity. These results further affirmed that 
antibacterial potency is not linearly correlated to the active 
P12 ligand content. Besides, during antibacterial tests, we 
observed aggregation of GNCs only with ≥60% P12 in feeding 
in LB culture media, suggesting significant non-specific 
interactions with negatively charged serum proteins in cell 
culture media, which could adversely affect their antibacterial 
potency. This result was consistent with their high positive 
zeta potentials. This represents a key drawback for such 
strongly positively-charged GNCs and other nanomaterials, 
which can greatly limit their applications as antibacterial 
reagents (SI, Figure S12). Therefore, in synthesising mixed 
ligand-capped GNCs, we must balance the active/inert ligand 
(P12/C5 here) ratio and determine their actual antibacterial 
properties in order to find out the optimal ligand ratio.
Biocompatibility and cytotoxicity
To determine the optimal ligand ratio, we performed a 
haemolytic test (SI, Figure S13). The resulting HD5 (the GNC 
dose that causes 5% haemolysis value against the P12 ligand-
feeding ratio was calculated for optimising the P12 feeding 
ratio (Figure 1F). The GNC haemolytic efficiency was enhanced 
(HD5 reduced) with the increasing P12 ligand content, which 
also indicated that increasing the ZW ligand ratio could reduce 
the cytotoxicity of GNCs. The GNC prepared with 45% P12 still 
maintained a relatively high HD5 of 34 μg mL-1, about twice 
that of the GNC prepared with 50% P12, while retaining almost 
the same MIC. Accordingly, GNCs prepared with >45% P12 
could be too cytotoxic, thus unfavourable for in vivo 
applications. To determine the optimal P12 feeding ratio, we 
plotted the HD5/MIC ratio versus P12 feeding ratio to 
collectively depict the change of biosafety and antibacterial 
activity of dual ligand GNCs. When the feeding ratio of P12 
























































































































6 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins
Please do not adjust margins
approached 45%, a sharp peak appeared, indicating GNC 
prepared with 45% P12 in feeding has a high antibacterial 
ability (low MIC) while maintaining low haemolyticity (high 
HD5), hence high biosafety, which is important for biomedical 
applications. This result also highlighted the importance of 
incorporating a certain proportion of ZW ligand in order to 
maintain good overall biocompatibility. 
We further evaluated the cytotoxicity of GNCs prepared with 
45% and 50% P12 ligand toward human umbilical vein 
endothelial cells (HUVECs). Compared with the 50%-P12 GNC, 
HUVECs demonstrated a much higher tolerance toward the 
45%-P12 GNC (Figure 1G), indicating a striking shift in 
cytotoxicity as the P12 feeding ratio reaches 50%. This result 
is consistent with the significantly lower HD5 value for the 50% 
P12 GNC observed above.
The use of excess cationic P12 ligand on GNC capping can lead 
to high cytotoxicity, adversely affecting its potential for in vivo 
application. However, too low the P12 ligand content can lead 
to low antibacterial activity. The key here is to balance the 
active/inert ligand ratio to achieve high stability and 
biocompatibility without compromising antibacterial potency.
The above results comprehensively proved that GNCs 
prepared with 45% P12 feeding ligand displayed excellent 
antibacterial activity, low cytotoxicity, and good stability. 
Therefore, the 45% P12 ligand-feeding ratio was considered 
optimal for preparing GNCs (denoted as GNC hereafter) for 
subsequent analyses.
Combinational antibacterial analyses
We considered that, besides the direct killing of bacteria, GNC 
could sensitise drug-resistant bacteria toward varied 
antibiotics to restore their antibacterial potency.44 To 
investigate this potential, we selected MRSE as the model 
microbe, to which our GNC demonstrated high inhibition. 
Seven antibiotics used to treat Gram-positive bacterial 
infections from four main categories: β-lactams (penicillin and 
carbapenem), glycopeptide, macrolides and tetracycline were 
tested. The result demonstrated that, except for vancomycin 
and tetracycline, all the other antibiotics exhibited low efficacy 
against this bacterial strain, with minimum inhibition 
concentrations (MICs) value ≥32 μg mL-1 (SI, Table S3). The test 
revealed high drug resistance of MRSE to several antibiotics.
A checkerboard method was further employed to evaluate the 
antibacterial properties of GNC and antibiotic combinational 
therapy.45,46 Imipenem (Imp), oxacillin (Oxa) and erythromycin 
(Ery), representing three classes of antibiotics, were applied 
with and without the GNC. Then, the fractional inhibitory 
concentration index (FICI) was calculated after 24 h of 
incubation. The calculated FICIs show that in joint applications, 
GNC exhibited the additive antibacterial ability with all three 
antibiotics (Figure 2A). Particularly, the Oxa group showed an 
exciting 128-fold decrease in antibiotic dosage needed to 
inhibit bacterial growth compared to the application of the 
antibiotic alone.
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Figure 2. Combinational antibacterial assay of GNC with antibiotics. (A) 24-h checkerboard results of the GNC with imipenem (Imp), oxacillin (Oxa), and erythromycin (Ery) (OD600 
values are given in the colour scale, a darker colour represents a higher bacteria concentration). The FICI was 1, 0.508, and 0.75 for GNC and Imp, Oxa, and Ery, respectively. (B) 
48-h checkerboard results of GNC with Imp, Oxa, and Ery. The FICI was ~0.5 for all three groups. This experiment revealed the combination bactericidal effect of GNC with varied 
types of antibiotics. (C) Undiluted plate-coating results of MRSE colonies after treatment with PBS buffer (control), different concentrations of Ery/Imp/Oxa and 16 μg mL-1 GNC 
to visually display changes in colonies. (D) Time-killing curves demonstrate a superior antibacterial efficiency of the combination of GNC and Imp compared to their separate 
applications. PBS buffer (control), Imp only (2 μg mL-1), GNC only (16 μg mL-1), and a combination of GNC (16 μg mL-1) and  Imp (2 μg mL-1) (n=3, ** 0.01 <P <0.05, ***P <0.01 and 
****P <0.001).  
We further prolonged the incubation to 48 h and re-measured 
FICI for each group (Figure 2B). The FICIs of all three groups 
were closer to 0.5, indicating the additive effect of GNC and 
antibiotics was enhanced. Specifically, adding 16 μg mL-1 of 
GNC and 2 μg mL-1 of any of the three tested antibiotics could 
prevent the growth of MRSE. We further took out the bacterial 
mixture and spread it onto agar plates to check the survival of 
MRSE and the agar plates remained unstained for the test 
groups compared with innumerable colonies for PBS control 
(Figure 2C). The results indicated that GNC had a remarkable 
ability to re-sensitise MRSE toward several antibiotics. Owing 
to the higher bactericidal efficiency, Imp was selected as the 
model antibiotics for further studies.
The MRSE-killing efficiency of this combination was measured 
by plotting the time-dependent killing graph (Figure 2D and SI, 
Figure S14). Compared to the PBS control, adding Imp did not 
significantly inhibit bacterial growth due to inherent high drug 
resistance. However, the GNC alone showed considerable 
bactericidal properties, giving rise to 105-fold lower MRSE 
densities at 24 h. The combined group showed the best 
results, where the amount of MRSE colony was ~40 and 100-
fold lower than that of the GNC-only group at 12 and 24 h, 
respectively. Impressively, the bacterial count of the GNC+Imp 
combination group was more than 107-fold lower than that of 
the control group at 24 h, demonstrating an excellent additive 
potency of the combined GNC and Imp in MRSE killing.
Antibacterial mechanisms
In general, cationic membrane-active molecules can exert 
several mechanisms to affect bacterial membrane function, 
for instance, attracting phospholipids to form defects and 
membrane leakage or perturbing membranes to induce lipid 
flip-flop.42 The damaged membrane causes detrimental 
membrane de-polarisation and spillage of cell contents, 
allowing antibiotics to penetrate the impaired bacterial 
defence for swift killing.47 The SEM images of MRSE cells 
revealed significant morphological differences after each 
different treatment (Figure 3A). For the negative control, all 
MRSE cells were spherical without apparent broken parts or 
wrinkles. Almost identical morphologies were observed for 
the Imp group, suggesting that the treatment with Imp alone 
did not cause noticeable damage to MRSE cells. In contrast, 
the GNC-treated group showed significantly altered cell 
morphologies and collapsed structures. The treated MRSE 
cells were tightly clustered together on a larger scale. A closer 
view revealed that the surface was covered with small grooves 
and wrinkles, indicating viability loss. This phenomenon was 
even more evident for the combined group (indicated with red 
arrows), where the grooves and wrinkles were deeper with a 
concave surface, indicating that the GNC+Imp combination 
could effectively agglutinate and deform bacterial cells, 
resulting in efficient bacterial killing. 
After treatment with GNC+Imp, the MRSE cells formed 
irregular clusters which could hinder migration. This 
phenomenon was further confirmed by the corresponding NIR 
fluorescence image of the aggregated MRSE cells (Figure 3B). 
This result indicated that GNCs covered the envelope of MRSE 
cells, allowing them to aggregate by neutralising their surface 
negative charges and form ‘bacterial clusters’ to limit spread 
and prolong the interaction.  
TEM images (Figure 3C) further confirmed the interaction of 
GNC with MRSE cells, which demonstrated the adhesion and 
penetration of GNCs within the cell envelope. Compared with 
the intact shape and apparent division septa for bacterial cells 
in the control group, the GNC+Imp treated group showed an 
abnormal cell division phenomenon: uneven division and 
empty cell walls were observed. Moreover, GNCs were mainly 
distributed within particular spaces on the cell envelope, 
indicating specific binding (indicated with red arrows).48 
Figure 3. GNC antibacterial mechanism investigation. (A) Typical SEM images of MRSE after a 4-h treatment of  PBS buffer (control), 2 μg mL-1 Imp, 16 μg mL-1 GNC, and a 
combination of Imp (2 μg mL-1) and GNC (16 μg mL-1). (B) Bright-field image (upper) and the corresponding NIR fluorescence image (lower) show that the GNC+Imp treated MRSE 
bacteria were extensively aggregated. (C) TEM images of PBS buffer (control group, upper) and 16 μg mL-1 GNC + 2 μg mL-1 Imp-treated MRSE (lower). 
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The antibacterial mechanism of GNC was further investigated. 
Although GNC binding-induced bacterial aggregation was 
already observed, it is still useful to investigate the specific 
binding target. The high abundance of negatively charged 
WTA may serve as a binding target for the positively charged 
GNCs via electrostatic interactions. Isothermal titration 
calorimetry (ITC) was conducted between GNCs and WTA, 
which revealed a multiple-binding endothermic interaction 
(SI, Figure S15A), indicating that WTA could initiate bacteria–
GNC interactions.49 To further verify this, a fluorescence 
competition assay with TR-Cadaverine was carried out. This 
dye can form a complex with WTA to quench its fluorescence. 
If GNC can compete with TR-Cadaverine in binding with WTA, 
adding GNC would result in dye release and fluorescence 
recovery. Figure S15B (SI) shows that the fluorescence of TR-
Cadaverine significantly increased with an increase in GNC 
concentration and was saturated at ~8 μg mL-1. Further 
increasing the GNC concentration could quench the dye 
fluorescence, possibly via dynamic quenching at high 
concentrations.50 These results confirmed that WTA was a 
binding target for the GNC.
The 45% P12-feeding ratio yielded Au25(P12)8(C5)10 as the 
primary product. Thus, we used this structure to simulate GNC 
binding with WTA by molecular binding simulation.51 A surface 
coverage state was established by simulating the GNC 
configurations (Figure 4A). Due to the electrostatic attractions 
between the cationic pyridinium and terminal anionic 
sulfonate groups, the ligands on the GNC surface are bended 
rather than pointing outward and form a ‘cage-like’ cap to 
stabilise the entire structure. This configuration explains the 
relatively high stability of GNC. Upon mixing with WTA, the 
electrostatic interactions between the GNC surface pyridinium 
groups and WTA phosphonate groups appeared to support 
GNC invasion of the bacterial cell envelope (Figure 4B). During 
this process, the cationic ligands interacted with the 
oppositely charged WTA layer, whereas the C5 ligands mainly 
pointed away from the surface. The initial electrostatic 
interactions further promote extensive contacts among the 
non-charged areas and strengthen their interactions via Van 
der Waals forces, which eventually contribute ~57% of the 
overall interaction (Figure 4C). Moreover, the weak hydrogen 
bonding between the WTA hydroxyl groups and pyridinium -
ring can further enhance the interaction (Figure 4D). WTA 
plays a vital role in drug resistance by providing attaching sites 
for other proteins that can replace synthases inhibited by 
penicillin antibiotics.45 Thus, the binding of GNCs to WTA may 
compromise the bacterial drug resistance and partially explain 
the sensitisation of MDR stains towards antibiotics when co-
treated with GNCs.
Figure 4. (A) Snapshot structure of an Au25(P12)8(C5)10 cluster obtained: Blue indicates 
C5; red indicates P12; yellow indicates thiol groups; pink indicates gold atoms. (B) Left: 
Snapshot of the GNC interaction with the WTA; right: scaled-up illustration of the 
interacting part. (C) Interaction energy between GNC and WTA. Coul represents 
Coulomb force, while VDW denotes Van der Waals force. (D) Number of hydrogen 
bond interactions between GNC and WTA units over 5-ns simulation.
Upon binding to the bacterial cell membrane, the positive charges 
on the GNC could induce membrane potential dissipation and 
cause cell death. In this study, the membrane potential was 
determined by measuring the ratio of green to red fluorescence 
using a fluorescent kit to stain the bacteria, where the green to red 
fluorescence ratio is linear with the membrane potential 
dissipation rate (Figure 5A and B). Adding only Imp did not cause a 
significant upheaval of green fluorescence, indicating that Imp had 
no apparent effect on the bacterial membrane potential. However, 
a sharp decrease in the red fluorescence and an increase in green 
fluorescence were observed for the GNC-treated MRSE cells, 
suggesting significant membrane potential dissipation. Membrane 
potential dissipation can severely interfere with normal 
physiological activities and cause cell death; thus, this result was 
consistent with the SEM and TEM images. Moreover, clustered 
bacteria were also observed in the GNC groups, indicating that 
membrane potential dissipation was related to the GNC-induced 
bacterial agglomeration.52
Inserting positively charged amphiphilic material has been 
shown to lysis cell membranes.53,54 The collapse of the MRSE 
cell structure, as observed in the SEM images, indicated that 
GNC could affect cell envelope completeness. To investigate 
whether the GNC treatment affected the integrity of cell 
membranes, we used a cell-integrity analysis kit, in which the 
dye can penetrate damaged membranes and bind to 
intracellular proteins. A positive correlation between the GNC 
concentration and dye incorporation confirmed that GNC 
could damage the integrity of the cell membrane (Figure 5C). 
The GNC+Imp combination exhibited even higher membrane 
permeation than the GNC-only treatment, consistent with the 
superior bactericidal potency. The antibacterial mechanism of 
Imp is to inhibit the synthesis of cell walls, thereby bursting the 
bacterial cells. By damaging bacterial cell membrane, GNC can 
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effectively enhance antibiotics transverse bacterial cell 
membranes, resulting in the additive bactericidal potency.
GNCs have been shown to generate ROS, which has 
bactericidal effects.12 Therefore, we studied ROS generation in 
all treatments (Figure 5D). Imp alone did not produce 
significant ROS, whereas GNC exhibited a good ability to 
generate ROS. Further addition of Imp did not increase ROS 
production. Therefore, only GNC is responsible for ROS 
production in the GNC+Imp combination. To investigate the 
exact species of ROS responsible here, we used two test kits 
to detect common ROS species, •O2− and •OH (Figure 5E). 
There was an increase in the production of •O2− but not •OH 
in the GNC treatments (Figure 5F). Hence, •O2− was confirmed 
to be the ROS species generated by the GNC treatment. Its 
high reactivity can damage cell membranes and other 
essential biological macromolecules to exert bactericidal 
effects. Some ROS-generating antibacterial materials have been 
found to have higher antibacterial activities on Gram-positive over 
Gram-negative strains, allowing them to be even used as Gram-
selective staining reagents55,56,57. The ROS generation ability of our 
GNC may also account for its higher antibacterial effect towards 
Gram-positive species like MRSE or S. aureus over Gram-negative 
ones.
Based on the above experimental results, our GNC exhibits 
four antibacterial mechanisms. 1) by binding to WTA, the GNC 
could interact and aggregate bacterial cells to control their 
spread and initiate subsequent antibacterial steps. 2) Its 
positive charges can interrupt the bacterial membrane 
potential, which may interfere with bacterial normal functions 
by disrupting the functions of some crucial enzymes58. 3) 
Simultaneously, the amphiphilic cationic ligands can disrupt 
the cell membrane, thus enhancing the permeation of 
antibiotics and improving their bactericidal effect, which, we 
believe, is the most important antibacterial mechanism of our 
GNCs59. 4) It can effectively generate ROS to damage the 
bacterial membrane and other vital genetic and cellular 
molecules. Combining all four bactericidal actions, the 
combination of GNC and antibiotics can effectively eliminate 
Gram-positive MDR bacteria like MRSE.
Figure 5. Investigating other possible antibacterial properties. (A) Membrane potential 
of MRSE cells after treatment in PBS buffer (control), 4 μg mL-1 Imp, 16 μg mL-1 GNC, 
and a combination of Imp (4 μg mL-1) and GNC (16 μg mL-1) (scale bar: 25 μm). (B) 
Comparison of the green-to-red fluorescent intensity ratios in different groups. (C) 
Comparison of the cell penetration rate at different concentrations of GNC 
with/without the addition of 4 μg mL-1 Imp (n=4). (D) Total ROS generation rate for the 
combination group compared with PBS control and individual application (n=3). (E) 
Superoxide anion generation rate of the combination group, the PBS (control) and 
single applications (n=3). (F) ROS colourimetric analysis results with the nitro-blue 
tetrazolium (NBT) method, which demonstrates no correlation between ·OH 
generation rate and the addition of GNC and Imp (n=3). 
Stability and cytotoxicity evaluation
The cytotoxicity of combined therapy on somatic (NIH 3T3 and 
HUVEC) cell lines was investigated by Calcein-AM/propidium iodide 
staining, where live/dead cells were stained in green/red, 
respectively. Confocal fluorescence images (SI, Figure S16A and B) 
reveal that most cells were alive with hardly noticeable numbers of 
dead cells, suggesting that both cell lines maintained high viability 
after 24-h incubation with 70 μg mL-1 of GNC + 30 μg mL-1 Imp. This 
was further verified by live-cell counting (SI, Figure S16C), where 
the percentage of live cells were above 80%, comparable to that of 
the controls. 
The stability of nanomaterials in storage is a crucial for its potential 
practical applications. We measured the UV-vis spectrum of freshly 
prepared GNC solution and after 3-month storage at 4 oC in a 
normal refrigerator (SI, Figure S17). We did not observe any 
deformation nor emergence of new peaks in the UV-vis spectrum. 
In addition, there were no changes in the physical appearance, 
aggregation, or precipitation, confirming the good stability of the 
GNC. 
NIR-II fluorescence is an attractive imaging modality that is 
well suited for in vivo applications. Owing to its attractive NIR 
fluorescence, GNC can act as fluorescent probes for organ 
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distribution tracking.60 We evaluated the GNC stability in vitro 
using simulated biological fluids. The GNC fluorescence (128 
μg mL-1) was highly stable and showed no observable changes 
after 15-day incubation in PBS supplemented with up to 10% 
human serum albumin (HSA, see SI, Figure S18). Thus, its 
stable NIR fluorescence can be used to directly evaluate the 
GNC organ distribution with a NIR animal imager using 808-nm 
laser irradiation (Figure 6A). Upon intravenous injection of 
GNC+Imp, strong NIR fluorescence was observed primarily in 
the liver with weak signals in the spleen and kidneys within the 
first hour, suggesting preferential accumulation in these 
organs. The NIR fluorescence in the main organs was 
maintained for 10 h, then it gradually faded away after 24 h 
and became almost invisible at 96-h post-injection, indicating 
that most of the GNCs were cleared from the body. The gold 
contents measured from critical organs harvested at different 
post-injection times were consistent with the NIR 
fluorescence results (>80% of the Au contents were cleared 
after 96 h, Figure 6B). These results indicate that the GNC has 
an adequate body clearance time and is suitable for intravenous 
administration. Moreover, the blood routine as well as liver and 
kidney function indicators further confirmed that a high dosage of 
GNC+Imp did not induce any notable change when compared with 
the control group, suggesting minimal in vivo toxicity (SI, Figures 
S19 A–F). 
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Figure 6. In vivo experiments demonstrate the appropriate clearance time and effective treatment effect. (A) NIR fluorescence of crucial organs of mice harvested at different 
time points under bright-field and 808-nm laser radiation (B: Brain, H: Heart, Int & St: Intestine and Stomach, Kid: Kidneys, Li: Liver, Lu: Lungs, Sp: Spleen, T: Thymus and U: 
Uterus). (B) Gold content (average weight) in different organs, harvested at different times post-injection (n=4). (C) Representative images of changes in wound size in different 
groups within 12 days post-treatment (scale bar: 10 mm). (D) Comparison of the relative wound size vs. time in different groups: PBS (control), 24 μg mL-1 Imp solution, 64 μg 
mL-1 GNC solution, and the combination of 24 μg mL-1 Imp (~0.12 mg kg-1, final concentration) and 64 μg mL-1 GNC solution (~0.32 mg kg-1, final concentration, same below) (n=3); 
(E) Plate coating results of the PBS control, single application, and combined therapy groups (n=3, *P >0.05, ** 0.01 <P <0.05 and ***P <0.01). (F) The hematoxylin-eosin staining 
graphs in different groups. After 12 days, the epidermis was fully reconstructed in the GNC+Imp group (Ly: lymphocytes; Ne: neutrophil; Ec: epithelial cell and Ef: elongated fiber).
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Skin infection model experiments
 As a coagulase-negative strain, MRSE can cause soft tissue and skin 
infections and frequently induces infection in surgical site5; thus, 
we established a skin infection model by creating wounds with 
removal of epidermis and dermis on the back of rats and infecting 
them with MRSE, to which conventional wound treatment 
methods are difficult to sustain antibacterial ability. Different 
groups were treated with either PBS control, Imp only, GNC 
only or GNC+Imp. The effect was monitored by measuring the 
wound size and bacterial counts after plate coating. Compared 
with the negative control, the wound healing rate for the rats 
treated with either Imp or GNC was higher. Notably, the 
wound healing of the GNC+Imp combinational group was the 
fastest. The size of the wound was significantly smaller than 
that of other groups, and the normal skin was almost fully 
reconstructed in 9 days (Figure 6C and D). Moreover, the scab 
size was significantly smaller than other groups, indicating a 
markedly reduced bacterial infection.
To quantify the clearance of bacteria on the skin wound, we 
performed plate coating to compare the number of colonies 
on differently treated wounds (Figure 6E). The MRSE counts of 
the negative control and Imp groups were slowly reduced over 
time due to autoimmunity, and the GNC-treated group 
showed a more significant decrease. Treatment with GNC+Imp 
resulted in the most rapid reduction of the bacterial 
population, and by day 12, the bacterial count was >10-fold 
lower than that of the GNC-only group and almost two orders 
of magnitude lower than that of the negative control group. 
This in vivo result was consistent with the superior in vitro 
antibacterial potency of GNC+Imp over that of GNC or Imp 
only. Pathological analyses further confirmed a complete 
repair of the wound tissue for the GNC+Imp group but not for 
the negative control and GNC- or Imp-only groups. The 
reconstruction of well-stratified skin layers and significantly 
reduced immune cells indicated the successful removal of the 
lesions in the GNC+Imp group (Figure 6F).
Conclusion
In this study, we synthesised a series of formula-defined 
pyridinium-zwitterionic ligand-functionalised 
Au25(SR1)x(SR2)18−x GNCs as antibacterial nanomaterials. By 
fine-tuning the feeding ligand ratios, we obtained GNCs that 
exhibited both excellent antibacterial ability and high stability, 
successfully addressed a major issue in antibacterial gold 
nanomaterials development. Besides, the GNCs exert multiple 
antibacterial mechanisms, giving rise to high potency against 
Gram-positive MDR bacteria. The optimized GNC can 
significantly reduce the dosage of antibiotics required to treat 
MDR bacterial infections, thereby greatly enhancing the 
efficacy of frontline antibiotics. Compared to other 
nanomaterials without defined chemical formulas, which 
could cause difficulties in quality control and mechanism 
research, our Au25(SR1)x(SR2)18-x GNCs are potentially better 
suited for medical applications. Moreover, biocompatible Au25 
GNCs capped with two, or more ligands can incorporate more 
functions, thus widening the scope of its biomedical 
applications. We envisage that dual/multi-ligand-
functionalised GNCs would find broad applications in 
chemistry, physics, biology, and biomedical sciences.
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